On Monday, Twist Bioscience Corp (NASDAQ: TWST) opened higher 5.37% from the last session, before settling in for the closing price of $27.95. Price fluctuations for TWST have ranged from $11.46 to $43.21 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 60.13%. Company’s average yearly earnings per share was noted 14.54% at the time writing. With a float of $55.30 million, this company’s outstanding shares have now reached $57.56 million.
The extent of productivity of a business whose workforce counts for 919 workers is very important to gauge.
Twist Bioscience Corp (TWST) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Twist Bioscience Corp is 4.36%, while institutional ownership is 114.11%. The most recent insider transaction that took place on Apr 09 ’24, was worth 18,434. In this transaction Chief Financial Officer of this company sold 556 shares at a rate of $33.16, taking the stock ownership to the 74,444 shares. Before that another transaction happened on Apr 02 ’24, when Company’s Chief Executive Officer sold 1,132 for $32.74, making the entire transaction worth $37,057. This insider now owns 514,149 shares in total.
Twist Bioscience Corp (TWST) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2023, the company posted -$0.75 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.78) by $0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.54% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Check out the current performance indicators for Twist Bioscience Corp (TWST). In the past quarter, the stock posted a quick ratio of 5.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.60, a number that is poised to hit -0.82 in the next quarter and is forecasted to reach -2.67 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
The latest stats from [Twist Bioscience Corp, TWST] show that its last 5-days average volume of 0.91 million was inferior to 0.92 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 17.67%. Additionally, its Average True Range was 1.72.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 31.68%, which indicates a significant increase from 29.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.93% in the past 14 days, which was lower than the 63.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.33, while its 200-day Moving Average is $27.42. Now, the first resistance to watch is $29.97. This is followed by the second major resistance level at $30.50. The third major resistance level sits at $31.50. If the price goes on to break the first support level at $28.44, it is likely to go to the next support level at $27.44. The third support level lies at $26.91 if the price breaches the second support level.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are currently 57,818K shares outstanding in the company with a market cap of 1.70 billion. Presently, the company’s annual sales total 245,110 K according to its annual income of -204,620 K. Last quarter, the company’s sales amounted to 71,500 K and its income totaled -43,010 K.
